Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,800

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

Open access
Ostrom, Quinn T, Gittleman, Haley, Liao, Peter, Vecchione-Koval, Toni, Wolinsky, Yingli, Kruchko, Carol, Barnholtz-Sloan, Jill S·2017·Neuro-Oncology
DOI 10.1093/neuonc/nox158
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/nox158

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 58

  1. 2007, WHO Classification of Tumours of the Central Nervous System
  2. 2014, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011, Neuro Oncol, 16, iv1
  3. 2009, The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry, J Neurooncol, 95, 401, 10.1007/s11060-009-9938-9 · DOI · Paper page
  4. 2015, Brain tumors in Sweden: data from a population-based registry 1999–2012, Acta Oncol, 54, 377, 10.3109/0284186X.2014.975369 · DOI
  5. 2000, International Classification of Diseases for Oncology, Third edition
  6. McCarthy BJ Surawicz T Bruner JM Kruchko C Davis F . Consensus Conference on Brain Tumor Definition for registration. November 10, 2000. Neuro Oncol. 2002;4(2):134–145. http://www.ncbi.nlm.nih.gov/pubmed/11916506. · DOI
  7. 2000, Tumours of the nervous system: World Health Organization classification of tumours
  8. 2016, WHO Classification of Tumours of the Central Nervous System
  9. 2015, Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004–2011, J Neuro Oncol
  10. 2005, International Classification of Childhood Cancer, third edition, Cancer, 103, 1457, 10.1002/cncr.20910 · DOI · Paper page
  11. Wickham H . ggplot2: elegant graphics for data analysis. 2009; http://had.co.nz/ggplot2/book. · DOI · Paper page
  12. 2006, Plotrix: a package in the red light district of R, R-News, 6, 8
  13. Tiwari RC Clegg LX Zou Z . Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15(6):547–569. http://www.ncbi.nlm.nih.gov/pubmed/17260923. · DOI · Paper page
  14. 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z · DOI · Paper page
  15. 2012, Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence, Cancer, 118, 1100, 10.1002/cncr.27405 · DOI
  16. 2014, Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer, 120, 1290, 10.1002/cncr.28509 · DOI · Paper page
  17. 2012, Cancer incidence among patients of the U.S. Veterans Affairs Health Care System, Mil Med, 177, 693, 10.7205/MILMED-D-11-00434 · DOI · Paper page
  18. Clegg LX Feuer EJ Midthune DN Fay MP Hankey BF . Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94(20):1537–1545. http://www.ncbi.nlm.nih.gov/pubmed/12381706. · DOI · Paper page
  19. 2005, Modeling Reporting Delays and Reporting Corrections in Cancer Registry Data, J Am Stat Assoc, 100, 61, 10.1198/016214504000001899 · DOI
  20. 2015, Alex’s Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011, Neuro Oncol, 16, x1, 10.1093/neuonc/nou327 · DOI · Paper page
  21. 1999, Chapter III: CNS and miscellaneous intracranial and intraspinal neoplasms
  22. 2015, Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009, Cancer Med
  23. 2016, American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008–2012, Neuro Oncol, 18, i1
  24. 2013, The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends, J Registry Manag, 40, 32
  25. 2015, Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States, Neuro Oncol, 17, 1166, 10.1093/neuonc/nov069 · doi:10.1093/neuonc/nov069
  26. 2016, Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010, Neuro Oncol
  27. 2003, Age-conditional probabilities of developing cancer, Stat Med, 22, 1837, 10.1002/sim.1428 · DOI
  28. 2004, Estimating age conditional probability of developing disease from surveillance data, Popul Health Metr, 2, 6, 10.1186/1478-7954-2-6 · DOI
  29. 2012, Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review, Neuro Oncol, 14, 1316, 10.1093/neuonc/nos208 · DOI · Paper page
  30. 2012, Epidemiology: allergy history, IgE, and cancer, Cancer Immunol Immunother, 61, 1493, 10.1007/s00262-011-1180-6 · DOI
  31. 2014, The epidemiology of glioma in adults: a “state of the science” review, Neuro Oncol, 16, 896, 10.1093/neuonc/nou087 · DOI · Paper page
  32. 2014, Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review, Cancer Epidemiol Biomarkers Prev, 23, 2716, 10.1158/1055-9965.EPI-14-0207 · DOI · Paper page
  33. 2010, Epidemiology and etiology of meningioma, J Neurooncol, 99, 307, 10.1007/s11060-010-0386-3 · DOI · Paper page
  34. 1998, Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas, J Natl Cancer Inst, 90, 1473, 10.1093/jnci/90.19.1473 · DOI · Paper page
  35. 2013, Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402, J Clin Oncol, 31, 337, 10.1200/JCO.2012.43.2674 · DOI · Paper page
  36. 2015, Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131, J Neurooncol, 124, 413, 10.1007/s11060-015-1845-7 · DOI
  37. 2013, Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951, J Clin Oncol, 31, 344, 10.1200/JCO.2012.43.2229 · DOI · Paper page
  38. TCGA Research Network, 2016, Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma, Cell, 164, 550, 10.1016/j.cell.2015.12.028 · DOI · Paper page
  39. 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, 352, 997, 10.1056/NEJMoa043331 · DOI · Paper page
  40. 2008, Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity, J Clin Oncol, 26, 4189, 10.1200/JCO.2007.11.5964 · DOI · Paper page
  41. 2007, Chemoradiotherapy in malignant glioma: standard of care and future directions, J Clin Oncol, 25, 4127, 10.1200/JCO.2007.11.8554 · DOI · Paper page
  42. Cancer Genome Atlas Research Network, 2010, Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma, Cancer Cell, 17, 510, 10.1016/j.ccr.2010.03.017 · DOI · Paper page
  43. 2013, MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic Oligodendrogliomas and Oligoastrocytomas. A report from EORTC study 26951, Clin Cancer Res, 19, 5513, 10.1158/1078-0432.CCR-13-1157 · DOI
  44. 2012, Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas, Acta Neuropathol, 123, 473, 10.1007/s00401-012-0958-8 · DOI · Paper page
  45. 2012, Molecular subgroups of medulloblastoma, Expert Rev Neurother, 12, 871, 10.1586/ern.12.66 · DOI
  46. 2012, Medulloblastomics: the end of the beginning, Nat Rev Cancer, 12, 818, 10.1038/nrc3410 · DOI · Paper page
  47. 2014, Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma, Nat Rev Cancer, 14
  48. 2014, The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma, Nat Genet, 46, 444, 10.1038/ng.2938 · DOI · Paper page
  49. 2016, Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics, Acta Neuropathol Commun, 4, 1, 10.1186/s40478-015-0269-0 · DOI · Paper page
  50. 2012, Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma, Pediatr Blood Cancer, 58, 489, 10.1002/pbc.24060 · DOI
  51. 2017, Genomic Insights into Diffuse Intrinsic Pontine Glioma, Front Oncol, 7, 57
  52. 2016, Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004–2012, varying), J Neuro Oncol
  53. 2014, Evaluation of North American Association of Central Cancer Registries’ (NAACCR) data for use in population-based cancer survival studies, J Natl Cancer Inst Monogr, 2014, 198, 10.1093/jncimonographs/lgu018 · DOI
  54. 2014, Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995–2008, J Registry Manag, 41, 65
  55. 1993, The new WHO classification of brain tumours, Brain Pathol, 3, 255, 10.1111/j.1750-3639.1993.tb00752.x · DOI · Paper page
  56. 2010, Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective, Acta Neuropathol, 120, 297, 10.1007/s00401-010-0725-7 · DOI · Paper page
  57. 2000, Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study, Cancer, 88, 2342, 10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO;2-X · DOI · Paper page
  58. 2014, Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma, Acta Neuropathol, 128, 551, 10.1007/s00401-014-1326-7 · DOI · Paper page

Cited by

See all 1,800

Metadata

Authors
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S.
Venue
Neuro-Oncology
Publisher
Oxford University Press (OUP)
Published
2017-10
Volume
19
Issue
suppl_5
Pages
v1-v88
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
DOI
10.1093/neuonc/nox158
OpenAlex
W4230172521
Cited by
1,800
References
5
FWCI
115.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. https://app.cochat.ai/papers/10.1093/neuonc/nox158
The paper
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2017). CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro-Oncology. https://doi.org/10.1093/neuonc/nox158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.